Induction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid-resistant nephrotic syndrome

American Journal of Pathology

Volumn 177, Issue 5, 2010, Pages 2225-2233

  Veron, Delma ^a   Reidy, Kimberly ^b   Marlier, Arnaud ^a   Bertuccio, Claudia ^a   Villegas, Guillermo ^b   Jimenez, Juan ^b   Kashgarian, Michael ^a   Tufro, Alda ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; METHYLPREDNISOLONE; NEPHRIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 164; VASCULOTROPIN A; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DOWN REGULATION; EMBRYO; GLOMERULOPATHY; HISTOPATHOLOGY; KIDNEY DEVELOPMENT; MOUSE; NEPHROTIC SYNDROME; NEWBORN; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; KIDNEY; LIPOID NEPHROSIS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEINURIA; ULTRASTRUCTURE;

ANIMALS; HUMANS; KIDNEY; MICE; MICE, TRANSGENIC; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PODOCYTES; PROTEINURIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78149298673     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091146     Document Type: Article

References (51)

1. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439
2. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442
3. Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors. Nat Med 2003, 9:669-676
4. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003, 111:707-716
5. Guan F, Villegas G, Teichman J, Mundel P, Tufro A: Autocrine VEGF-A system in podocytes regulates podocin and its interactions with CD2AP. Am J Physiol Renal Physiol 2006, 291:F422-F428
6. Schrijvers BF, Flyvbjerg A, De Vriese AS: The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 2004, 65:2003-2017
7. Quaggin SE and Coffman TM: Toward a mouse model of diabetic nephropathy is endothelial nitric oxide synthase the missing link? J Am Soc Nephrol 2007, 18:364-367
8. Veron D, Reidy K, Bertuccio C, Techman J, Villegas G, Jimenez J, Shen W, Kopp J, Thomas D, Tufro A: Induction of podocyte VEGF-A overexpression in adult mice causes glomerular disease Kidney Int 2010, 77:989-999
9. Kaukinen A, Kuusniemi AM, Lautenschlager I, Jalanko H: Glomerular endothelium in kidneys with congenital nephrotic syndrome of the Finnish type (NPHS1). Nephrol Dial Transplant 2008, 23:1224-1232
10. Kestilä M, Lenkkeri U, Männikkö M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1998, 1:575-582
11. Putaala H, Soininen R, Kilpeläinen P, Wartiovaara J, and Tryggvason K: The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001, 10:1-8
12. Boute N, Roselli S, Gribouval O, Niaudet P, Gubler MC, Antignac C: Characterization of the NPH2 gene, coding for the glomerular protein podocin, implicated in a familial form of cortico-resistant nephrotic syndrome transmitted as an autosomal recessive. Nephrologie 2002, 23:35-36
13. Donoviel DB, Freed DD, Vogel H, Potter DG, Hawkins E, Barrish JP, Mathur BN, Turner CA, Geske R, Montgomery CA, Starbuck M, Brandt M, Gupta A, Ramirez-Solis R, Zambrowicz BP, Powell DR: Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol 2001, 21:4829-4836
14. Ciani L, Patel A, Allen ND, ffrench-Constant C: Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol Cell Biol 2003, 23:3575-3582
15. Natoli TA, Liu J, Eremina V, Hodgens K, Li C, Hamano Y, Mundel P, Kalluri R, Miner JH, Quaggin SE, Kreidberg JA: A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol 2002, 13:2058-2067
16. Jones N, Blasutig IM, Eremina V, Ruston JM, Bladt F, Li H, Huang H, Larose L, Li SS, Takano T, Quaggin SE, Pawson T: Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006, 440:818-823
17. Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA: Management of childhood onset nephrotic syndrome. Pediatrics 2009, 124:747-757
18. Shalhoub RJ: Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974, 2:556-560
19. Garin EH, Laflam PF, Muffly K: Proteinuria and fusion of podocyte foot processes in rats after infusion of cytokine from patients with idiopathic minimal lesion nephrotic syndrome. Nephron Exp Nephrol 2006, 102:e105-e112
20. Webb NJ, Watson CJ, Roberts IS, Bottomley MJ, Jones CA, Lewis MA, Postlethwaite RJ, Brenchley PE: Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome. Kidney Int 1999, 55:1063-1071
21. Cheong HI, Lee JH, Hahn H, Park HW, Ha IS, Choi Y: Circulating VEGF and TGF-β1 in children with idiopathic nephrotic syndrome. J Nephrol 2001, 14:263-269
22. Wasilewska A, Zoch-Zwierz W: Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome. Acta Paediatr 2006, 95:587-593
23. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M: Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998, 341:309-315
24. Xing CY, Saleem MA, Coward RJ, Ni L, Witherden IR, Mathieson PW: Direct effects of dexamethasone on human podocytes. Kidney Int 2006, 70:1038-1045
25. Shigehara T, Zaragoza C, Kitiyakara C, Takahashi H, Lu H, Moeller M, Holzman LB, Kopp JB: Inducible podocyte-specific gene expression in transgenic mice. J Am Soc Nephrol 2003, 14:1998-2003
26. Akeson AL, Greenberg JM, Cameron JE, Thompson FY, Brooks SK, Wiginton D, Whitsett JA: Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung. Dev Biol 2003, 264:443-455
27. Yuen PS, Dunn SR, Miyaji T, Yasuda H, Sharma K, Star RA: A simplified method for HPLC determination of creatinine in mouse serum. Am J Physiol Renal Physiol 2004, 286:F1116-F1119
28. Doumas BT, Watson WA, Biggs HG: Albumin standards and the measurement of serum albumin with bromocresol green. Clin Chim Acta 1971, 31:87-96
29. Marlier A, Schmidt-Ott KM, Gallagher AR, Barasch J, Karihaloo A: Vegf as an epithelial cell morphogen modulates branching morphogenesis of embryonic kidney by directly acting on the ureteric bud. Mech Dev 2009, 126:91-98
30. Hader C, Marlier A, Cantley L: Mesenchymal-epithelial transition in epithelial response to injury: the role of Foxc2. Oncogene 2010, 29:1031-1040
31. Hirose K, Osterby R, Nozawa M and Gundersen HJ: Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 1982, 21:689-695
32. Roselli S, Heidet L, Sich M, Henger A, Kretzler M, Gubler MC, Antignac C: Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 2004, 24:550-560
33. Lahdenkari AT, Lounatmaa K, Patrakka J, Holmberg C, Wartiovaara J, Kestilä M, Koskimies O, Jalanko H: Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol 2004, 15:2611-2618
34. Vats AN, Costello B, Mauer M: Glomerular structural factors in progression of congenital nephrotic syndrome. Pediatr Nephrol 2003, 18:234-240
35. Roberts WG, Palade GE: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995, 108:2369-2379
36. Ioannidou S, Deinhardt K, Miotla J, Bradley J, Cheung E, Samuelsson S, Ng YS, Shima DT: An in vitro assay reveals a role for the diaphragm protein PV-1 in endothelial fenestra morphogenesis. Proc Natl Acad Sci USA 2006, 103:16770-16775
37. Satchell SC, Braet F: Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol 2009, 296:F947-F956
38. Churg J, Habib R, White RH: Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 1970, 760:1299-1302
39. Tufró A: VEGF spatially directs angiogenesis during metanephric development in vitro. Dev Biol 2000, 227:558-566
40. Fogo A, Hawkins EP, Berry PL, Glick AD, Chiang ML, MacDonell RC Jr, Ichikawa I: Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 1990, 38:115-123
41. Wernerson A, Dunér F, Pettersson E, Widholm SM, Berg U, Ruotsalainen V, Tryggvason K, Hultenby K, Söderberg M: Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome. Nephrol Dial Transplant 2003, 18:70-76
42. Verma R, Kovari I, Soofi A, Nihalani D, Patrie K, Holzman LB: Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation. Nck recruitment, and actin polymerization J Clin Invest 2006, 116:1346-1359
43. Seiler MW, Venkatachalam MA, Cotran RS: Glomerular epithelium: structural alterations induced by polycations. Science 1975, 189: 390-393
44. Li H, Zhu J, Aoudjit L, Latreille M, Kawachi H, Larose L, Takano T: Rat nephrin modulates cell morphology via the adaptor protein Nck Biochem Biophys Res Commun 2006, 349:310-316
45. Uchida K, Suzuki K, Iwamoto M, Kawachi H, Ohno M, Horita S, Nitta K: Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis. Kidney Int 2008, 73:926-932
46. Garin EH: Circulating mediators of proteinuria in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 2000, 14:872-878
47. Yamauchi K, Takano Y, Kasai A, Hayakawa K, Hiramatsu N, Enomoto N, Yao J, Kitamura M: Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes. Kidney Int 2006, 70:892-900
48. Fujii Y, Khoshnoodi J, Takenaka H, Hosoyamada M, Nakajo A, Bessho F, Kudo A, Takahashi S, Arimura Y, Yamada A, Nagasawa T, Ruotsalainen, Tryggvason K, Lee AS, Yan K: The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases. Kidney Int 2006, 69:1350-1359
49. Xing Y, Ding J, Fan Q, Guan N: Diversities of podocyte molecular changes induced by different antiproteinuria drugs. Exp Biol Med (Maywood) 2006, 231:585-593
50. Fan Q, Xing Y, Ding J, Guan N: Reduction in VEGF protein and phosphorylated nephrin associated with proteinuria in Adriamycin nephropathy rats. Nephron Exp Nephrol 2009, 111:e92-e102
51. Heiss JD, Papavassiliou E, Merrill MJ, Nieman L, Knightly JJ, Walbridge S, Edwards NA, Oldfield EH: Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor J Clin Invest 1996, 98:1400-1408